Cargando…
Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region
Malaria is an infectious disease caused by Plasmodium parasites. It results in an annual death-toll of ~ 600,000. Resistance to all medications currently in use exists, and novel antimalarial drugs are urgently needed. Plasmepsin V (PmV) is an essential Plasmodium protease and a highly promising ant...
Autores principales: | Gambini, Luca, Rizzi, Luca, Pedretti, Alessandro, Taglialatela-Scafati, Orazio, Carucci, Mario, Pancotti, Andrea, Galli, Corinna, Read, Martin, Giurisato, Emanuele, Romeo, Sergio, Russo, Ilaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643876/ https://www.ncbi.nlm.nih.gov/pubmed/26566224 http://dx.doi.org/10.1371/journal.pone.0142509 |
Ejemplares similares
-
Correction: Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region
por: Gambini, Luca, et al.
Publicado: (2016) -
Plasmepsin-like Aspartyl Proteases in Babesia
por: Šnebergerová, Pavla, et al.
Publicado: (2021) -
Experimental Determination of the Membrane Topology of the Plasmodium Protease Plasmepsin V
por: Tarr, Sarah J., et al.
Publicado: (2015) -
New Hopes for Drugs against COVID-19 Come from the Sea
por: Taglialatela-Scafati, Orazio
Publicado: (2021) -
Editor-in-Chief’s Letter to Readers and Authors of Marine Drugs
por: Taglialatela-Scafati, Orazio
Publicado: (2021)